Cosmos Health Inc. (COSM) Fair Value 2026

COSM · Wholesale-Drugs, Proprietaries & Druggists' Sundries ·

By CirclFi Research Team · Data from SEC EDGAR, FRED & GDELT

Quality Score

3.9 /10

32 fundamental signals · 8 models active

Value Trap Risk

LOW (36/100)

Quick Summary — As of 2026-07-13, Cosmos Health Inc. (COSM) trades at $0.31. QOC: 3.9/10. Value Trap Risk: 36/100 (LOW). 8/13 models active.

Key Facts

Ticker
COSM
Price
$0.31
Quality Score
3.9/10
Value Trap Risk
36/100
Models Active
8/13
Last Updated
Strength: CUCE Ensemble suggests +70.9% upside with 3% confidence
Risk: Below-average Quality Score of 3.9/10 signals weak fundamentals

Valuation Matrix

8 Intrinsic Value Models vs. Current Price ($0.31)

Core Models (Unlocked)
Model Fair Value Upside
Earnings Power Value
Medium Conviction
$0.15 -49.9%
CUCE Ensemble
Low Conviction
$0.53 +70.9%
ML-RIV
Medium Conviction
$0.48 +55.9%
PWERM
Medium Conviction
$0.31 +1.1%

Unlock the Full Matrix

Access 4 additional models including EROIC Spread, Regime Cross-Sectional, and more.

$1.30 / day

Billed monthly ($39/mo) or annually ($299/yr)

Unlock All 8 Models →

Cancel anytime · No contracts · Instant access

What Is Cosmos Health Inc. (COSM) Worth in 2026?

According to the CirclFi Deep Alpha Valuation Engine, our multi-model framework produces a cautiously optimistic read on Cosmos Health Inc. at $0.31. With an estimated intrinsic value of $0.67 and 5 of 8 models pointing higher, the average implied return is +117.0%. The most optimistic model, Regime Cross, places fair value at $1.82 (+490.5%), while EPV — the most conservative — estimates $0.15 (-49.9%). This +540.4% gap reflects genuine analytical uncertainty about Cosmos Health Inc.'s intrinsic worth.

What Do the Models Say About COSM?

8 of 13 models are currently active for COSM. Of these, 6 models suggest upside while 2 models suggest overvaluation. See which stocks rank higher →

How Does COSM Rank in Wholesale-Drugs, Proprietaries & Druggists' Sundries?

Among 10 Wholesale-Drugs, Proprietaries & Druggists' Sundries stocks, COSM ranks #8 by Quality of Company score. CirclFi's QOC score of 3.9/10 evaluates 32 fundamental signals. A score of 3.9 signals below-average fundamentals.

The Wholesale-Drugs, Proprietaries & Druggists' Sundries sector introduces analytical considerations specific to pharmaceutical industry businesses. For Cosmos Health Inc., metrics like patent cliff exposure provide important context that general-purpose valuation models may underweight.

Is COSM a Value Trap?

CirclFi's Value Trap algorithm assigns COSM a score of 36/100 (LOW). This indicates low risk. The financial profile does not exhibit typical value trap warning signs. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →

Multi-Model Methodology

8 of 13 models are active for Cosmos Health Inc.. Moderate coverage provides meaningful perspective. Each model applies a fundamentally different valuation philosophy. See the complete methodology →

According to the CirclFi Deep Alpha Valuation Engine, Cosmos Health Inc. scores 3.9 out of 10 on our 32-signal quality assessment, a moderate rating that shows mixed signals across our quality framework with notable weaknesses. The QOC score synthesizes profitability margins, revenue growth reliability, debt management, and capital allocation into a single metric designed to separate durable businesses from statistically cheap ones.

The gap between the most bullish and bearish model spans +540.4% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →

Data Sources & Confidence

Every COSM valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →

Across COSM's 8 active models, average confidence is 25%. Lower confidence may reflect limited history or high volatility.

CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →

This analysis is produced by the CirclFi Valuation Engine using quantitative models applied to SEC EDGAR filings, public market feeds, and FRED macroeconomic indicators. It is not financial advice.

Read the full investment analysis: Should You Buy Cosmos Health Inc. Stock in 2026? →

Bull case, bear case, risk factors & peer comparison — updated daily

Which Similar Wholesale-Drugs, Proprietaries & Druggists' Sundries Stocks Should You Also Analyze?

8 related Wholesale-Drugs, Proprietaries & Druggists' Sundries stocks with 13-model coverage

Read investment analysis: MCK · COR · CAH · HLF · NUS

Frequently Asked Questions About Cosmos Health Inc.

What is Cosmos Health Inc.'s intrinsic value in 2026?

Based on CirclFi's 13-model analysis, Cosmos Health Inc. (COSM) has multiple fair value estimates. The Bayesian DCF model runs 10,000 Monte Carlo simulations with jump-diffusion to estimate intrinsic value. The Quality of Company score is 3.9/10 across 32 fundamental signals. All models use SEC EDGAR filings updated daily. See our methodology page for how each model works.

Is COSM overvalued or undervalued right now?

At $0.31, 6 of 8 active models suggest COSM may be undervalued, while 2 indicate potential overvaluation. The assessment depends on which methodology best fits Cosmos Health Inc.'s business model in Wholesale-Drugs, Proprietaries & Druggists' Sundries.

What does a Quality of Company score of 3.9 mean for COSM?

Cosmos Health Inc.'s QOC of 3.9/10 reflects 32 fundamental signals: profitability margins, revenue growth consistency, balance sheet leverage, free cash flow generation, and capital allocation efficiency. Scores below 5 flag potential fundamental weaknesses requiring careful analysis.

How many valuation models does CirclFi run on COSM?

CirclFi analyzes COSM with 13 institutional-grade models daily: Bayesian DCF (Monte Carlo + jump-diffusion), EPV (Greenwald zero-growth), EROIC Spread (McKinsey reinvestment), First Chicago (3-scenario), Markov DDM (regime-switching), ML-RIV (machine learning residual income), Dynamic NAV (asset-based), PWERM (option-theoretic), Regime Cross-Sectional (relative), Sentiment SOTP (hybrid), CUCE Ensemble (meta-model), FTNN Topology (neural network), and RCMH-DCF (conditional regime). Currently 8 of 13 are active for this stock. Read the full methodology →

Is COSM a value trap in 2026?

Cosmos Health Inc.'s Value Trap score is 36/100 (LOW). This low score indicates the current valuation is not artificially depressed by fundamental deterioration, suggesting genuine opportunity rather than a trap. Browse stocks by value-trap risk →

You’ve done the research. Don’t stop at half the picture.

Stop collecting opinions. Let 8 mathematical frameworks give you clarity on COSM.

Unlock All 8 Fair Values — $39/mo

Cancel anytime · Less than a cup of coffee · Instant access